KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Share-based Compensation: 2015-2025

Historic Share-based Compensation for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $6.3 million.

  • Medpace Holdings' Share-based Compensation fell 46.08% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.1 million, marking a year-over-year increase of 41.41%. This contributed to the annual value of $25.5 million for FY2024, which is 24.36% up from last year.
  • Medpace Holdings' Share-based Compensation amounted to $6.3 million in Q3 2025, which was up 6.25% from $6.0 million recorded in Q2 2025.
  • Medpace Holdings' Share-based Compensation's 5-year high stood at $16.9 million during Q1 2025, with a 5-year trough of $2.9 million in Q1 2021.
  • Over the past 3 years, Medpace Holdings' median Share-based Compensation value was $5.4 million (recorded in 2023), while the average stood at $6.8 million.
  • In the last 5 years, Medpace Holdings' Share-based Compensation plummeted by 47.27% in 2021 and then skyrocketed by 291.93% in 2025.
  • Medpace Holdings' Share-based Compensation (Quarterly) stood at $4.0 million in 2021, then soared by 40.49% to $5.6 million in 2022, then fell by 7.65% to $5.2 million in 2023, then climbed by 14.02% to $5.9 million in 2024, then crashed by 46.08% to $6.3 million in 2025.
  • Its last three reported values are $6.3 million in Q3 2025, $6.0 million for Q2 2025, and $16.9 million during Q1 2025.